{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:41:29Z","timestamp":1770702089170,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.exer.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:44:21Z","timestamp":1450226661000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation"],"prefix":"10.1016","volume":"145","author":[{"given":"Tohru","family":"Sakimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.exer.2015.12.005_bib1","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.4049\/jimmunol.172.9.5638","article-title":"Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in\u00a0vivo antiviral effect of an adenoviral vector expressing murine IFN-beta","volume":"172","author":"Al-Khatib","year":"2004","journal-title":"J.\u00a0Immunol."},{"issue":"4","key":"10.1016\/j.exer.2015.12.005_bib2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1476-5381.2012.01836.x","article-title":"Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational study","volume":"166","author":"Balagu\u00e9","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.exer.2015.12.005_bib3","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/jid.2009.25","article-title":"Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis","volume":"129","author":"Boy","year":"2009","journal-title":"J.\u00a0Invest. Dermatol"},{"issue":"12","key":"10.1016\/j.exer.2015.12.005_bib4","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1021\/jm401490p","article-title":"Discovery and development of janus kinase (JAK) inhibitors for inflammatory diseases","volume":"57","author":"Clark","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"issue":"11","key":"10.1016\/j.exer.2015.12.005_bib5","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1038\/jid.2010.196","article-title":"A\u00a0comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: upregulation of dectin-1 in psoriasis","volume":"130","author":"de Koning","year":"2010","journal-title":"J.\u00a0Invest. Dermatol"},{"issue":"6","key":"10.1016\/j.exer.2015.12.005_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis","volume":"367","author":"Fleischmann","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.exer.2015.12.005_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ni.1701","article-title":"Selectivity and therapeutic inhibition of kinases: to be or not to be?","volume":"10","author":"Ghoreschi","year":"2009","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.exer.2015.12.005_bib8","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J.\u00a0Immunol."},{"issue":"2","key":"10.1016\/j.exer.2015.12.005_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1096\/fj.06-6925com","article-title":"IFNgamma synergizes with IL-1beta to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis","volume":"21","author":"Harris","year":"2007","journal-title":"Faseb. J."},{"issue":"7","key":"10.1016\/j.exer.2015.12.005_bib10","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ophtha.2012.03.017","article-title":"Immunomodulatory effect of the topical ophthalmic janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease","volume":"119","author":"Huang","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.exer.2015.12.005_bib11","first-page":"599","article-title":"The high affinity Fc gamma receptor (CD64) induces phagocytosis in the absence of its cytoplasmic domain: the gamma subunit of Fc gamma RIIIA imparts phagocytic function to Fc gamma RI","volume":"22","author":"Indik","year":"1994","journal-title":"Exp. Hematol."},{"issue":"7","key":"10.1016\/j.exer.2015.12.005_bib12","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/art.24567","article-title":"The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase II a trial of three dosage levels of CP-690,550 versus placebo","volume":"60","author":"Kremer","year":"2009","journal-title":"Arthritis. Rheum."},{"issue":"8","key":"10.1016\/j.exer.2015.12.005_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI0215755","article-title":"Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus","volume":"110","author":"Lee","year":"2002","journal-title":"J.\u00a0Clin. Invest"},{"issue":"7","key":"10.1016\/j.exer.2015.12.005_bib14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ophtha.2012.01.028","article-title":"Tofacitinib (CP-690,550), a janus kinase inhibitor for dry eye disease: results from a phase 1\/2 trial","volume":"119","author":"Liew","year":"2012","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.exer.2015.12.005_bib15","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.167.9.5150","article-title":"Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha","volume":"167","author":"Ma","year":"2001","journal-title":"J.\u00a0Immunol."},{"issue":"12","key":"10.1016\/j.exer.2015.12.005_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1741-7015-12-43","article-title":"What is the future of targeted therapy in rheumatology: biologics or small molecules?","volume":"13","author":"M\u00f3csai","year":"2014","journal-title":"BMC Med. Mar."},{"issue":"5","key":"10.1016\/j.exer.2015.12.005_bib17","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J.\u00a0Immunol."},{"issue":"4","key":"10.1016\/j.exer.2015.12.005_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/jid.2013.476","article-title":"Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib","volume":"134","author":"Okiyama","year":"2014","journal-title":"J.\u00a0Invest. Dermatol"},{"issue":"9","key":"10.1016\/j.exer.2015.12.005_bib19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/01.tp.0000177643.05739.cd","article-title":"Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts","volume":"80","author":"Paniagua","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.exer.2015.12.005_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.2012.11168.x","article-title":"Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, in the treatment of psoriasis: a phase 2b randomized placebo-controlled dose-ranging study","volume":"167","author":"Papp","year":"2012","journal-title":"Br. J. Dermatol"},{"issue":"5","key":"10.1016\/j.exer.2015.12.005_bib21","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)62358-9","article-title":"Expression of smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali","volume":"166","author":"Saika","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.exer.2015.12.005_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10384-008-0536-8","article-title":"Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing","volume":"52","author":"Sakimoto","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2015.12.005_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.exer.2012.02.015","article-title":"Anti-inflammatory effect of IL-6 receptor blockade in corneal alkali burn","volume":"97","author":"Sakimoto","year":"2012","journal-title":"Exp. Eye. Res."},{"issue":"9","key":"10.1016\/j.exer.2015.12.005_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00417-014-2708-1","article-title":"Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients","volume":"252","author":"Sakimoto","year":"2014","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"issue":"8","key":"10.1016\/j.exer.2015.12.005_bib25","doi-asserted-by":"crossref","first-page":"e72291","DOI":"10.1371\/journal.pone.0072291","article-title":"Interferon-gamma increases the ratio of matrix metalloproteinase-9\/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease","volume":"8","author":"Springall","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.exer.2015.12.005_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/ICO.0000000000000019","article-title":"Effects of topical janus kinase inhibition on ocular surface inflammation and immunity","volume":"33","author":"Stevenson","year":"2014","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.exer.2015.12.005_bib27","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1002\/art.37691","article-title":"Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors","volume":"64","author":"Yarilina","year":"2012","journal-title":"Arthritis. Rheum."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483515300907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483515300907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T13:42:48Z","timestamp":1572270168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483515300907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":27,"alternative-id":["S0014483515300907"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2015.12.005","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}